Document is current
Any future updates will be listed below
-
Authors
Szydłowski, Maciej
Kurtz, Ewa
Garbicz, Filip
Maroszek, Julia
Pawlak, Michał
Ochocka, Natalia
Tabaka, Marcin
Prochorec-Sobieszek, Monika
Szumera-Ciećkiewicz, Anna
Górniak, Patryk https://orcid.org/0000-0002-2920-2672
Szymańska-Giemza, Olga
Rymkiewicz, Grzegorz
Kołkowska-Leśniak, Agnieszka
Kukwa, Wojciech
Paszkiewicz-Kozik, Ewa
Totoń-Żurańska, Justyna
Radomska, Sylwia
Pilch, Zofia
Nowis, Dominika https://orcid.org/0000-0003-2748-9523
Golab, Jakub https://orcid.org/0000-0002-2830-5100
Kurlapski, Michał https://orcid.org/0000-0002-6134-7425
Zaucha, Jan Maciej
Braczko, Alicja
Kaszkowiak, Marcin
Wołkow, Paweł
Wiktorska, Katarzyna
Brognard, John
Lichołai, Sabina
Lech-Marańda, Ewa
Juszczyński, Przemysław https://orcid.org/0000-0001-7215-0444
-
Funding
Funding for this research was provided by:
Narodowe Centrum Nauki (2016/22/M/NZ5/00668)
- License Information
-
More Information
Article History
Received: 5 August 2025
Revised: 24 November 2025
Accepted: 15 December 2025
First Online: 26 December 2025
Competing interests
: PJ: consultancy for Ryvu Therapeutics, received research funding from Menarini Richerche.
: Institutional review board approval was obtained for the collection and analysis of tissue samples from patients (Decision number 22/2019). Animal studies were performed according to the protocol approved by the local bioethical committee and were performed in accordance with the guidelines approved by the 2nd Local Ethics Committee in Warsaw and in accordance with the requirements of the EU (Directive 2010/63/EU) and Polish (Dz. U. poz. 266/15.01.2015) legislation.
: All patients provided informed consent for participation and utilization of biopsy specimens in this study.
